ABSI Stock Price, Absci Corporation Quote, Chart

Market Summary

USD4.62-0.12

Market Closed

-2.53%

ABSI Stock Price

View Fullscreen

ABSI RSI Chart

ABSI Valuation

Market Cap

522.4M

Price/Earnings (Trailing)

-4.78

Price/Sales (Trailing)

97.71

EV/EBITDA

-4.73

Price/Free Cashflow

-8.3

ABSI Price/Sales (Trailing)

ABSI Profitability

EBT Margin

-2040.04%

Return on Equity

-45.47%

Return on Assets

-39.72%

Free Cashflow Yield

-12.05%

ABSI Fundamentals

ABSI Revenue

Revenue (TTM)

5.3M

Rev. Growth (Yr)

-29.24%

Rev. Growth (Qtr)

165.68%

ABSI Earnings

Earnings (TTM)

-109.2M

Earnings Growth (Yr)

5.91%

Earnings Growth (Qtr)

6.67%

Breaking Down ABSI Revenue

Last 7 days

-5.9%

Last 30 days

-12.7%

Last 90 days

-13.3%

Trailing 12 Months

291.5%

How does ABSI drawdown profile look like?

ABSI Financial Health

Current Ratio

7.19

ABSI Investor Care

Shares Dilution (1Y)

22.25%

Diluted EPS (TTM)

-1.16

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	5.3M	0	0	0
2023	6.2M	8.6M	6.9M	5.7M
2022	4.7M	4.7M	5.5M	5.7M
2021	4.8M	4.9M	4.9M	4.9M
2020	0	0	0	4.8M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Absci Corporation

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 19, 2024	mcclain sean	acquired	-	-	1,500,000	chief executive officer
Mar 01, 2024	redmile group, llc	bought	999,999	4.5	222,222	-
Feb 01, 2024	busch andreas	acquired	-	-	83,125	chief innovation officer
Feb 01, 2024	mcclain sean	acquired	-	-	182,000	chief executive officer
Feb 01, 2024	jonasson zachariah	acquired	-	-	114,010	cfo / cbo
Feb 01, 2024	bedrick todd	acquired	-	-	20,570	svp, cao
Nov 28, 2023	phoenix venture partners ii lp	sold	-58,248	1.4404	-40,439	-
Nov 27, 2023	phoenix venture partners ii lp	sold	-18,165	1.4018	-12,959	-
Nov 24, 2023	phoenix venture partners ii lp	sold	-15,326	1.4219	-10,779	-
Nov 22, 2023	phoenix venture partners ii lp	sold	-4,927	1.4047	-3,508	-

Which funds bought or sold ABSI recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	COMERICA BANK	new	-	31,150	31,150	-%
May 16, 2024	JANE STREET GROUP, LLC	added	61.68	1,220,030	2,248,300	-%
May 15, 2024	MILLENNIUM MANAGEMENT LLC	added	235	7,837,060	10,053,600	-%
May 15, 2024	JACOBS LEVY EQUITY MANAGEMENT, INC	sold off	-100	-58,976	-	-%
May 15, 2024	HSBC HOLDINGS PLC	unchanged	-	546,156	2,315,050	-%
May 15, 2024	KENNEDY CAPITAL MANAGEMENT LLC	new	-	358,414	358,414	0.01%
May 15, 2024	WELLINGTON MANAGEMENT GROUP LLP	new	-	816,841	816,841	-%
May 15, 2024	MORGAN STANLEY	added	174	549,181	751,914	-%
May 15, 2024	AMERIPRISE FINANCIAL INC	reduced	-3.14	165,980	701,480	-%
May 15, 2024	STATE STREET CORP	added	20.86	593,959	1,529,990	-%

Are Funds Buying or Selling ABSI?

Are funds buying ABSI calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own ABSI

No. of Funds

Unveiling Absci Corporation's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Mar 05, 2024	redmile group, llc	4%	8,282,016	SC 13D/A
Feb 14, 2024	phoenix venture partners ii lp	15.5%	14,379,522	SC 13G/A
Feb 13, 2024	mcclain sean	10.0%	9,373,113	SC 13G
Feb 09, 2024	fmr llc	-	0	SC 13G/A
May 08, 2023	casdin capital, llc	4.8%	4,448,260	SC 13D/A
Mar 20, 2023	casdin capital, llc	6.%	5,533,260	SC 13D/A
Feb 14, 2023	phoenix venture partners ii lp	15.7%	14,492,813	SC 13G/A
Feb 14, 2023	mcclain sean	9.8%	9,083,128	SC 13G/A
Feb 13, 2023	casdin capital, llc	7.0%	6,473,260	SC 13D/A
Feb 13, 2023	absci corp	9.8%	9,083,128	SC 13G

Recent SEC filings of Absci Corporation

View All Filings

Date Filed	Form Type	Document
May 14, 2024	10-Q	Quarterly Report
May 14, 2024	8-K	Current Report
Apr 23, 2024	ARS	ARS
Apr 23, 2024	DEF 14A	DEF 14A
Apr 23, 2024	DEFA14A	DEFA14A
Mar 21, 2024	10-K	Annual Report
Mar 21, 2024	4	Insider Trading
Mar 21, 2024	8-K	Current Report
Mar 21, 2024	S-8	Employee Benefits Plan
Mar 05, 2024	4	Insider Trading

Peers (Alternatives to Absci Corporation)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
MRNA	50.9B	6.8B	28.49%	6.05%	-8.53	7.44	-64.45%	-224.75%
HILS	22.5B	216.3K	-0.77%	465779.94%	-2.5K	104.0K	-	-8.13%
ALNY	18.9B	2.0B	2.79%	-21.33%	-56.9	9.43	75.20%	68.82%
BMRN	14.7B	2.5B	-14.30%	-15.94%	71.65	5.96	13.74%	186.89%
INCY	12.8B	3.8B	8.33%	-10.25%	17.2	3.4	8.58%	129.81%
MID-CAP
BBIO	5.6B	107.9M	20.58%	115.45%	-10.31	48.09	54.84%	-28.31%
APLS	5.0B	524.1M	-13.99%	-52.79%	-12.02	9.57	394.93%	39.61%
AXSM	3.6B	251.0M	9.96%	-0.29%	-12.28	14.5	73.58%	-86.73%
ARWR	3.1B	240.7M	9.94%	-31.73%	-6.53	12.77	-1.03%	-213.43%
ACAD	2.4B	813.8M	-14.08%	-36.34%	-1.4K	3	56.43%	98.83%
SMALL-CAP
CPRX	1.9B	411.3M	3.06%	35.16%	29.91	4.73	60.38%	-34.49%
NVAX	1.8B	996.6M	233.93%	75.07%	-4.57	1.83	-26.66%	65.49%
CRBP	480.9M	881.7K	21.10%	351.81%	-14.25	481.06	-77.61%	33.36%
INO	310.9M	4.9M	8.40%	53.85%	-2.49	63.89	-54.97%	48.23%
IBIO	17.1M	2.1M	4.76%	108.64%	-0.74	7.61	-13.45%	69.54%

Absci Corporation News

Latest updates

Absci Corporation Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3
Revenue	165.7%	898,000	338,000	744,000	3,367,000	1,269,000	1,557,000	2,369,000	1,002,000	819,000	1,292,500	1,539,000	1,047,000	1,063,000	989,500	916,000
Operating Expenses	-2.7%	24,396,000	25,077,000	24,047,000	46,355,000	25,754,000	22,650,000	30,336,000	29,889,000	29,622,000	27,708,000	22,681,000	17,420,000	12,211,000	-	4,280,000
S&GA Expenses	-6.2%	8,744,000	9,324,000	9,505,000	9,410,000	9,593,000	7,749,000	11,407,000	10,507,000	10,889,000	9,183,000	9,733,000	5,179,000	4,685,000	-	1,257,000
R&D Expenses	-0.3%	12,236,000	12,269,000	11,029,000	12,112,000	12,657,000	11,315,000	15,525,000	16,241,000	15,827,000	15,766,000	10,730,000	11,040,000	7,050,000	-	2,692,000
EBITDA Margin	-5.6%	-17.64	-16.69	-13.23	-11.38	-13.73	-15.90	-17.98	-20.86	-24.49	-20.19	-2.57	-2.59	-	-	-
Interest Expenses	-13.7%	176,000	204,000	229,000	256,000	321,000	287,000	279,000	211,000	195,000	200,000	768,000	2,009,000	455,000	-	172,000
Income Taxes	-75.0%	12,000	48,000	34,000	11,000	7,000	-500,000	-312,000	-270,000	621,000	-1,099,000	-1,703,000	-5,600,000	-500,000	-	-
Earnings Before Taxes	6.5%	-21,963,000	-23,497,000	-21,960,000	-41,661,000	-23,348,000	-19,971,000	-27,571,000	-28,950,000	-28,873,000	-26,268,000	-25,337,000	-46,815,000	-11,439,000	-	-3,748,000
EBT Margin	-5.6%	-20.40	-19.32	-15.42	-13.15	-16.11	-18.33	-20.37	-23.52	-27.10	-22.23	-2.93	-2.95	-	-	-
Net Income	6.7%	-21,975,000	-23,545,000	-21,994,000	-41,672,000	-23,355,000	-19,471,000	-27,259,000	-28,680,000	-29,494,000	-25,166,000	-23,634,000	-41,198,000	-10,962,000	-4,939,000	-3,748,000
Net Income Margin	-5.6%	-20.42	-19.34	-15.35	-13.05	-15.94	-18.25	-20.17	-22.99	-25.44	-20.43	-16.47	-12.52	-	-	-
Free Cashflow	-19.6%	-17,863,000	-14,939,000	-10,668,000	-19,490,000	-20,399,000	-19,128,000	-23,913,000	-26,467,000	-28,006,000	-25,395,000	-27,367,000	-32,234,000	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet													(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2020Q4
Assets	26.5%	275	217	236	254	296	321	339	366	395	426	449	257	89.00
Current Assets	50.8%	182	121	135	148	165	187	201	228	256	273	301	112	73.00
Cash Equivalents	5.5%	76.00	72.00	70.00	61.00	11.00	60.00	124	223	251	280	307	127	72.00
Goodwill	-	-	-	-	-	21.00	21.00	21.00	21.00	21.00	21.00	23.00	23.00	-
Liabilities	-15.4%	35.00	41.00	40.00	39.00	42.00	47.00	46.00	50.00	55.00	60.00	61.00	220	22.00
Current Liabilities	-14.4%	25.00	30.00	28.00	25.00	27.00	30.00	30.00	32.00	42.00	34.00	30.00	30.00	10.00
Shareholder's Equity	36.3%	240	176	196	215	254	274	293	316	340	366	388	-	-
Retained Earnings	-5.4%	-428	-406	-382	-360	-319	-295	-276	-249	-220	-191	-165	-142	-90.06
Additional Paid-In Capital	14.8%	669	583	579	576	573	570	569	565	561	557	554	18.00	1.00
Shares Outstanding	21.4%	113	93.00	93.00	93.00	92.00	92.00	93.00	91.00	90.00	93.00	73.00	17.00	-
Float	-	-	-	-	92.00	-	-	-	176	-	-	-	1,200	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2
Cashflow From Operations	-19.7%	-17,863	-14,922	-10,361	-19,234	-20,119	-18,568	-19,043	-22,579	-21,149	-17,079	-21,747	-14,487	-7,285	-	-	-
Share Based Compensation	12.9%	3,590	3,179	2,544	3,041	2,652	1,024	3,567	4,209	3,740	3,232	3,783	1,441	2,152	-	-	-
Cashflow From Investing	-504.5%	-76,681	18,958	20,135	70,152	-27,301	-30,179	-78,723	-11,223	-6,857	-8,316	-6,820	-43,365	-8,876	-	-	-
Cashflow From Financing	6673.6%	81,184	-1,235	-924	-1,220	-1,104	1,393	-921	5,823	-1,058	-1,296	208,387	-474	129,576	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

ABSI Income Statement

2024-03-31

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues
Technology development revenue	$ 898	$ 1,269
Total revenues	898	1,269
Operating expenses
Research and development	12,236	12,657
Selling, general and administrative	8,744	9,593
Depreciation and amortization	3,416	3,504
Total operating expenses	24,396	25,754
Operating loss	(23,498)	(24,485)
Other income (expense)
Interest expense	(176)	(321)
Other income, net	1,711	1,458
Total other income, net	1,535	1,137
Loss before income taxes	(21,963)	(23,348)
Income tax expense	(12)	(7)
Net loss	$ (21,975)	$ (23,355)
Net loss per share: basic (in usd per share)	$ (0.22)	$ (0.26)
Net loss per share: diluted (in usd per share)	$ (0.22)	$ (0.26)
Weighted-average common shares outstanding: basic (in shares)	99,393,333	91,479,452
Weighted-average common shares outstanding: diluted (in shares)	99,393,333	91,479,452
Comprehensive loss:
Net loss	$ (21,975)	$ (23,355)
Foreign currency translation adjustments	(47)	(14)
Unrealized (loss) gain on investments	(48)	39
Comprehensive loss	$ (22,070)	$ (23,330)
Revenue from Contract with Customer, Product and Service [Extensible Enumeration]	License and Service [Member]	License and Service [Member]

ABSI Balance Sheet

2024-03-31

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 58,831	$ 72,362
Restricted cash	16,350	16,193
Short-term investments	102,712	25,297
Receivables under development arrangements, net	42	2,189
Prepaid expenses and other current assets	3,863	4,537
Total current assets	181,798	120,578
Operating lease right-of-use assets	4,275	4,490
Property and equipment, net	38,755	41,328
Intangibles, net	47,411	48,253
Restricted cash, long-term	1,126	1,112
Other long-term assets	1,533	1,537
TOTAL ASSETS	274,898	217,298
Current liabilities:
Accounts payable	1,653	1,503
Accrued expenses	15,398	19,303
Long-term debt	3,301	3,258
Operating lease obligations	1,586	1,679
Financing lease obligations	287	641
Deferred revenue	3,063	3,174
Total current liabilities	25,288	29,558
Long-term debt, net of current portion	3,745	4,660
Operating lease obligations, net of current portion	5,296	5,643
Finance lease obligations, net of current portion	29	76
Deferred tax liability, net	175	186
Deferred revenue, long-term	180	966
Other long-term liabilities	78	33
TOTAL LIABILITIES	34,791	41,122
STOCKHOLDERS' EQUITY
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding	0	0
Common stock, $0.0001 par value; 500,000,000 shares authorized; 112,998,922 and 93,087,675 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	11	9
Additional paid-in capital	668,698	582,699
Accumulated deficit	(428,470)	(406,495)
Accumulated other comprehensive loss	(132)	(37)
TOTAL STOCKHOLDERS' EQUITY	240,107	176,176
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 274,898	$ 217,298

About Absci Corporation

Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver, Washington.

CEO	Mr. Sean McClain
WEBSITE	absci.com
INDUSTRY	Biotechnology
EMPLOYEES	193

Absci Corporation Frequently Asked Questions

What is the ticker symbol for Absci Corporation? What does ABSI stand for in stocks?

ABSI is the stock ticker symbol of Absci Corporation. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Absci Corporation (ABSI)?

As of Fri May 17 2024, market cap of Absci Corporation is 522.45 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ABSI stock?

You can check ABSI's fair value in chart for subscribers.

What is the fair value of ABSI stock?

You can check ABSI's fair value in chart for subscribers. The fair value of Absci Corporation is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Absci Corporation is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ABSI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Absci Corporation a good stock to buy?

The fair value guage provides a quick view whether ABSI is over valued or under valued. Whether Absci Corporation is cheap or expensive depends on the assumptions which impact Absci Corporation's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ABSI.

What is Absci Corporation's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, ABSI's PE ratio (Price to Earnings) is -4.78 and Price to Sales (PS) ratio is 97.71. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ABSI PE ratio will change depending on the future growth rate expectations of investors.